Cargando…

Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomas

BACKGROUND: In this study we aimed to quantify tumor suppressor gene (TSG) promoter methylation densities levels in primary neuroblastoma tumors and cell lines. A subset of these TSGs is associated with a CpG island methylator phenotype (CIMP) in other tumor types. METHODS: The study panel consisted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiss, Nimrod B, Kogner, Per, Johnsen, John Inge, Martinsson, Tommy, Larsson, Catharina, Geli, Janos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495052/ https://www.ncbi.nlm.nih.gov/pubmed/22984959 http://dx.doi.org/10.1186/1471-2350-13-83

Ejemplares similares

Genome-wide methylation profiling identifies novel methylated genes in neuroblastoma tumors
por: Olsson, Maja, et al.
Publicado: (2016)

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
por: Djos, Anna, et al.
Publicado: (2012)

Aggressive neuroblastomas have high p110alpha but low p110delta and p55alpha/p50alpha protein levels compared to low stage neuroblastomas
por: Fransson, Susanne, et al.
Publicado: (2013)

Aneuploidy in neuroblastoma tumors is not associated with inactivating point mutations in the STAG2 gene
por: Djos, Anna, et al.
Publicado: (2013)

The loss of DLG2 isoform 7/8, but not isoform 2, is critical in advanced staged neuroblastoma
por: Keane, Simon, et al.
Publicado: (2021)

Tumor Development, Growth Characteristics and Spectrum of Genetic Aberrations in the TH-MYCN Mouse Model of Neuroblastoma
por: Rasmuson, Agnes, et al.
Publicado: (2012)

The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytes
por: Carlson, Lena-Maria, et al.
Publicado: (2013)

Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes
por: Thorell, Kaisa, et al.
Publicado: (2009)

Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma
por: Carén, Helena, et al.
Publicado: (2011)

Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validation
por: Cetinkaya, Cihan, et al.
Publicado: (2013)

The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis
por: Snapkov, Igor, et al.
Publicado: (2016)

Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors
por: Kryh, Hanna, et al.
Publicado: (2011)

Multifocal Neuroblastoma and Central Hypoventilation in An Infant with Germline ALK F1174I Mutation
por: Djos, Anna, et al.
Publicado: (2022)

Low Frequency ALK Hotspots Mutations In Neuroblastoma Tumours Detected By Ultra-deep Sequencing: Implications For ALK Inhibitor Treatment
por: Javanmardi, Niloufar, et al.
Publicado: (2019)

Immune suppression by myeloid-derived suppressor cells, MDSCs, in MYCN-driven neuroblastoma provides a potential target for cancer immunotherapy
por: Eissler, Nina, et al.
Publicado: (2014)

Inhibition of Microsomal Prostaglandin E Synthase-1 in Cancer-Associated Fibroblasts Suppresses Neuroblastoma Tumor Growth
por: Kock, Anna, et al.
Publicado: (2018)

The immune cell atlas of human neuroblastoma
por: Verhoeven, Bronte Manouk, et al.
Publicado: (2022)

Whole-genome sequencing of recurrent neuroblastoma reveals somatic mutations that affect key players in cancer progression and telomere maintenance
por: Fransson, Susanne, et al.
Publicado: (2020)

Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours
por: Carén, H, et al.
Publicado: (2007)

High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: Four cases of homozygous deletions of the CDKN2A gene
por: Carén, Helena, et al.
Publicado: (2008)

SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells In Vitro
por: Tümmler, Conny, et al.
Publicado: (2019)

Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastoma
por: Dyberg, Cecilia, et al.
Publicado: (2016)

SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma
por: Astuti, D, et al.
Publicado: (2004)

Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2 (SSTR2) gene at 17q24
por: Abel, F, et al.
Publicado: (1999)

Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
por: Hald, Øyvind H., et al.
Publicado: (2018)

Autocrine Prostaglandin E(2) Signaling Promotes Tumor Cell Survival and Proliferation in Childhood Neuroblastoma
por: Rasmuson, Agnes, et al.
Publicado: (2012)

Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation
por: Treis, Diana, et al.
Publicado: (2022)

Filamin A increases aggressiveness of human neuroblastoma
por: Bandaru, Sashidar, et al.
Publicado: (2022)

Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene.
por: EjeskÃ¤r, K., et al.
Publicado: (1998)

PPM1D Is a Therapeutic Target in Childhood Neural Tumors
por: Milosevic, Jelena, et al.
Publicado: (2021)

Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma
por: Chand, Damini, et al.
Publicado: (2013)

Neuroblastoma-related inflammation: May small doses of aspirin be suitable for small cancer patients?
por: Carlson, Lena-Maria, et al.
Publicado: (2013)

Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability in vitro and impairs tumor growth in vivo
por: Tümmler, Conny, et al.
Publicado: (2017)

Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib
por: Guan, Jikui, et al.
Publicado: (2018)

Acquired hypermethylation of the P16(INK4A) promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutation
por: Kiss, Nimrod B, et al.
Publicado: (2013)

High Expression of PPM1D Induces Tumors Phenotypically Similar to TP53 Loss-of-Function Mutations in Mice
por: Milosevic, Jelena, et al.
Publicado: (2021)

Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup
por: Martinez-Monleon, Angela, et al.
Publicado: (2022)

A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation
por: Carén, Helena, et al.
Publicado: (2005)

DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma
por: Olsen, Thale Kristin, et al.
Publicado: (2022)

Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma
por: Astuti, D, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_n18k7c2ih5tl7feavo4cd2aud8